The FDA Boss on the Agency’s MAHA Makeover
The Journal.
00:00
Enhancing FDA Communication and Drug Approval
This chapter focuses on improving interactions between the FDA and pharmaceutical companies to streamline drug development and reduce overregulation. It also discusses the introduction of a new system for expedited drug reviews linked to pricing commitments, the use of AI technologies, and the need for clear vaccine regulations.
Transcript
Play full episode
